Drug Profile
Lamivudine/zidovudine - Cipla
Alternative Names: Zidovudine/lamivudine - CiplaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Cipla
- Class Antiretrovirals; Azides; Dideoxynucleosides; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Nucleoside reverse transcriptase inhibitors; RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV infections
Most Recent Events
- 05 Dec 2018 Lamivudine/zidovudine is not yet available in USA for HIV infections indication (Cipla website, November 2018)